Kenneth M. Tichauer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kenneth M. Tichauer has a total of 247 co-authors. Here are the top co-authors by number of shared publications:
- Brian W. Pogue
Dartmouth College, Thayer School of Engineering, Hanover, New Hampshire, United States
21 shared publications Ting-Yim Lee
18 shared publicationsKeith St. Lawrence
Department of Medical Biophysics, Western University, Ontario N6A 3K7, Canada
14 shared publicationsKimberley S. Samkoe
Thayer School of Engineering, Dartmouth College, Hanover, USA
11 shared publicationsJovan G. Brankov
Oral and Maxillofacial Surgery, University Medical Center Groningen, Gronigen, Netherlands
10 shared publicationsJonathan T. Elliott
Thayer School of Engineering at Dartmouth
9 shared publications
Latest Publications
- Open Access
Synchrotron diffraction reveals distinct collagen-associated distributions of EGFR-targeted antibody and affibody in pancreatic tumors
Tumor extracellular matrix may influence the distribution of targeted agents differently across molecular formats. We compared how an antibody and an affibody targeting the same receptor distribute relative to collagen-associated tissue structure in pancreatic tumors. Methods: Cetuximab-IRDye700DX, an epidermal growth factor receptor (EGFR)-targeted fluorescent antibody, and ABY-029, an EGFR-targeted fluorescent affibody, were co-administered intravenously to 12 athymic nude mice bearing orthotopic pancreatic tumors: eight AsPC-1 and four PANC-1. Tumors were harvested at 3 or 24 h after injection, with four AsPC-1 and two PANC-1 mice at each time. Fluorescence images from 21 tissue slices were registered to scanning synchrotron X-ray diffraction (XRD) maps to compare each agent’s distribution with local collagen-associated diffraction intensity. Results: Cetuximab–XRD correlations were negative in all 12 mice at every evaluated binning scale (100–400 µm; all adjusted P = 0.0039). Cohort-average correlations were more negative for cetuximab than ABY-029 at all four scales (paired adjusted P = 0.0137–0.0381). At 400 µm, mean correlations were −0.502 and −0.249, respectively. ABY-029 correlations did not differ significantly from zero after adjustment. Vehicle controls showed positive background fluorescence–XRD associations. Conclusions: Cetuximab exhibited consistent inverse spatial associations with collagen-associated diffraction and stronger cohort-average associations than ABY-029. These findings show that agents targeting the same receptor can differ in their relationships with local tissue structure and support spatially resolved assessment of tissue access when selecting molecular formats for imaging and therapy.
Open AccessSynchrotron diffraction reveals distinct collagen-associated distributions of EGFR-targeted antibody and affibody in pancreatic tumors
Tumor extracellular matrix may influence the distribution of targeted agents differently across molecular formats. We compared how an antibody and an affibody targeting the same receptor distribute relative to collagen-associated tissue structure in pancreatic tumors. Methods: Cetuximab-IRDye700DX, an epidermal growth factor receptor (EGFR)-targeted fluorescent antibody, and ABY-029, an EGFR-targeted fluorescent affibody, were co-administered intravenously to 12 athymic nude mice bearing orthotopic pancreatic tumors: eight AsPC-1 and four PANC-1. Tumors were harvested at 3 or 24 h after injection, with four AsPC-1 and two PANC-1 mice at each time. Fluorescence images from 21 tissue slices were registered to scanning synchrotron X-ray diffraction (XRD) maps to compare each agent’s distribution with local collagen-associated diffraction intensity. Results: Cetuximab–XRD correlations were negative in all 12 mice at every evaluated binning scale (100–400 µm; all adjusted P = 0.0039). Cohort-average correlations were more negative for cetuximab than ABY-029 at all four scales (paired adjusted P = 0.0137–0.0381). At 400 µm, mean correlations were −0.502 and −0.249, respectively. ABY-029 correlations did not differ significantly from zero after adjustment. Vehicle controls showed positive background fluorescence–XRD associations. Conclusions: Cetuximab exhibited consistent inverse spatial associations with collagen-associated diffraction and stronger cohort-average associations than ABY-029. These findings show that agents targeting the same receptor can differ in their relationships with local tissue structure and support spatially resolved assessment of tissue access when selecting molecular formats for imaging and therapy.
- Open Access
- 30 October 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (21) , 215001
Correction of arterial input-function saturation for extraction fraction estimation in retinal fluorescein videoangiography
Objective . Quantitative retinal fluorescein videoangiography (FVA) can estimate extraction fraction ( E ), but the 8-bit intensity resolution of clinical systems creates a dynamic-range tradeoff: preserving arterial input function (AIF) linearity can restrict tissue signal, particularly for pixel-level analysis. We developed a single-bolus correction method to broaden the usable acquisition range while maintaining E estimation accuracy. Approach . The method combined truncated-mean reconstruction when sufficient unsaturated arterial pixels remained with gamma-variate interpolation when saturation dominated the first-pass peak. Development simulations used four human-derived AIF templates, empirically characterized signal-dependent noise, and 20 paired realizations evaluated over arterial scaling factors f = 0.1–2.25. Tissue curves were generated using a distributed-transit-time AATH model and fitted using a plug-flow AATH model. The locked correction threshold was then evaluated by artificially clipping raw arterial-pixel time curves from 10 originally undersaturated FVAs without adding synthetic noise. Performance was compared with the clipped arterial mean, piecewise cubic Hermite interpolation, and gamma-variate interpolation alone. Main results . The combined method completed all 60 patient-by-clipping analyses and produced lower first-pass peak, normalized mean squared error (NMSE), and area-under-the-curve errors than the comparator methods under moderate-to-strong clipping. In kinetic simulations, mean absolute relative ROI E error with the uncorrected AIF increased from 17 ± 9% at f = 1.25–60 ± 20% at f = 2.25, whereas corrected-AIF error remained approximately 10%–20%. Single-pixel E error decreased as signal approached the detector ceiling, reached 17 ± 11% at f = 1.75, and remained statistically similar across f = 0.8–2.0. No single-pixel fits failed at f ⩾ 1.0. Significance . The correction framework converts modest AIF saturation from a restrictive acquisition limit into a manageable analytical condition. This broader operating range is valuable for 8-bit FVA, supporting acquisition near the detector ceiling to improve tissue signal and enable high-resolution E mapping without dual-bolus acquisition.
- 30 October 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (21) , 215001
Open AccessCorrection of arterial input-function saturation for extraction fraction estimation in retinal fluorescein videoangiography
Objective . Quantitative retinal fluorescein videoangiography (FVA) can estimate extraction fraction ( E ), but the 8-bit intensity resolution of clinical systems creates a dynamic-range tradeoff: preserving arterial input function (AIF) linearity can restrict tissue signal, particularly for pixel-level analysis. We developed a single-bolus correction method to broaden the usable acquisition range while maintaining E estimation accuracy. Approach . The method combined truncated-mean reconstruction when sufficient unsaturated arterial pixels remained with gamma-variate interpolation when saturation dominated the first-pass peak. Development simulations used four human-derived AIF templates, empirically characterized signal-dependent noise, and 20 paired realizations evaluated over arterial scaling factors f = 0.1–2.25. Tissue curves were generated using a distributed-transit-time AATH model and fitted using a plug-flow AATH model. The locked correction threshold was then evaluated by artificially clipping raw arterial-pixel time curves from 10 originally undersaturated FVAs without adding synthetic noise. Performance was compared with the clipped arterial mean, piecewise cubic Hermite interpolation, and gamma-variate interpolation alone. Main results . The combined method completed all 60 patient-by-clipping analyses and produced lower first-pass peak, normalized mean squared error (NMSE), and area-under-the-curve errors than the comparator methods under moderate-to-strong clipping. In kinetic simulations, mean absolute relative ROI E error with the uncorrected AIF increased from 17 ± 9% at f = 1.25–60 ± 20% at f = 2.25, whereas corrected-AIF error remained approximately 10%–20%. Single-pixel E error decreased as signal approached the detector ceiling, reached 17 ± 11% at f = 1.75, and remained statistically similar across f = 0.8–2.0. No single-pixel fits failed at f ⩾ 1.0. Significance . The correction framework converts modest AIF saturation from a restrictive acquisition limit into a manageable analytical condition. This broader operating range is valuable for 8-bit FVA, supporting acquisition near the detector ceiling to improve tissue signal and enable high-resolution E mapping without dual-bolus acquisition.
- Open Access
- 1 May 2026
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 31 (05) , 1-3
Advancing small-animal molecular imaging through multifaceted innovation
The editorial highlights articles in a JBO special section, as well as emerging trends in small-animal molecular imaging.
- 1 May 2026
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 31 (05) , 1-3
Open AccessAdvancing small-animal molecular imaging through multifaceted innovation
The editorial highlights articles in a JBO special section, as well as emerging trends in small-animal molecular imaging.
- Open Access
- 25 November 2025
- Published by Springer Nature in npj Imaging
- Vol. 3 (1) , 62
Reflect: reporting guidelines for preclinical, translational and clinical fluorescence molecular imaging studies
Fluorescence molecular imaging (FMI) is becoming a powerful tool to improve surgical precision and diagnostics. Although significant advances have been made in imaging technology and contrast agents, debate continues regarding suitable standards for FMI. Standardizing all FMI aspects is crucial for adoption in clinical procedures and routine practice. Currently, the lack of clear-cut guidelines on FMI study reporting complicates comparison between studies and impedes standardization. This work presents community-driven REFLECT guidelines for FMI study reporting for fluorescence-guided surgery and interventions, covering preclinical, translational, and clinical studies. It aims to improve quality of reporting, enable comparison between studies, and enhance interpretation of results. The resulting structured checklist encompasses all essential details for reporting on the contrast agent, imaging device, imaging protocol, and image processing and analysis methods. Adoption of this framework is encouraged to enhance reproducibility and establish alignment with standardization efforts in the field - thus fostering advancements in FMI.
- 25 November 2025
- Published by Springer Nature in npj Imaging
- Vol. 3 (1) , 62
Open AccessReflect: reporting guidelines for preclinical, translational and clinical fluorescence molecular imaging studies
Fluorescence molecular imaging (FMI) is becoming a powerful tool to improve surgical precision and diagnostics. Although significant advances have been made in imaging technology and contrast agents, debate continues regarding suitable standards for FMI. Standardizing all FMI aspects is crucial for adoption in clinical procedures and routine practice. Currently, the lack of clear-cut guidelines on FMI study reporting complicates comparison between studies and impedes standardization. This work presents community-driven REFLECT guidelines for FMI study reporting for fluorescence-guided surgery and interventions, covering preclinical, translational, and clinical studies. It aims to improve quality of reporting, enable comparison between studies, and enhance interpretation of results. The resulting structured checklist encompasses all essential details for reporting on the contrast agent, imaging device, imaging protocol, and image processing and analysis methods. Adoption of this framework is encouraged to enhance reproducibility and establish alignment with standardization efforts in the field - thus fostering advancements in FMI.
- Open Access
- 29 March 2025
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 30 (04) , 046001-16
Dual-channel pulse-dye densitometry can enable correction of fluorescent targeted and control agent plasma input function differences for quantitative paired-agent molecular imaging: a simulation study
In recent years, paired-agent imaging (PAI) strategies have been explored owing to their ability to yield quantitative in vivo imaging of cell-surface receptors.1 – 3 PAI requires the administration of at least two imaging agents of similar blood and tissue kinetics where one agent is targeted to a biomolecule of interest and one is untargeted (the “control” agent). By measuring the dynamics of the control agent, non-specific accumulation of the targeted agent and variable targeted agent delivery (attributable to the variability of blood flow and vascular permeability among tissues, particularly cancerous tissues) can potentially be accounted for, allowing for more quantitative estimates of the targeted agent’s specific binding through the approximation of a quantity termed the “binding potential” (BP). BP is directly proportional to the concentration of an agent’s biomolecular target,4 and as such, the measurement of this quantity can give critical insight into the disease state and phenotype of a biological tissue. In the context of surgical oncology, BP mapping (compared with targeted agent distribution mapping) may enable improved discrimination between malignant and non-malignant tissue types.5,6
- 29 March 2025
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 30 (04) , 046001-16
Open AccessDual-channel pulse-dye densitometry can enable correction of fluorescent targeted and control agent plasma input function differences for quantitative paired-agent molecular imaging: a simulation study
In recent years, paired-agent imaging (PAI) strategies have been explored owing to their ability to yield quantitative in vivo imaging of cell-surface receptors.1 – 3 PAI requires the administration of at least two imaging agents of similar blood and tissue kinetics where one agent is targeted to a biomolecule of interest and one is untargeted (the “control” agent). By measuring the dynamics of the control agent, non-specific accumulation of the targeted agent and variable targeted agent delivery (attributable to the variability of blood flow and vascular permeability among tissues, particularly cancerous tissues) can potentially be accounted for, allowing for more quantitative estimates of the targeted agent’s specific binding through the approximation of a quantity termed the “binding potential” (BP). BP is directly proportional to the concentration of an agent’s biomolecular target,4 and as such, the measurement of this quantity can give critical insight into the disease state and phenotype of a biological tissue. In the context of surgical oncology, BP mapping (compared with targeted agent distribution mapping) may enable improved discrimination between malignant and non-malignant tissue types.5,6
- 1 January 2025
- Published by Optica Publishing Group
- p. OTh2D.2
A paired-agent fluorescence tomography method to detect and localize cancer burden in excised lymph nodes
This work presents a method to detect and localize cancer burden in surgically excised lymph nodes from head and neck cancer patients. Results from porcine lymph nodes implanted with human head and neck cancer spheroids demonstrate that cancer cell clusters as small as 100-microns can be detected with >99% sensitivity and specificity within 30 min.
- 1 January 2025
- Published by Optica Publishing Group
- p. OTh2D.2
A paired-agent fluorescence tomography method to detect and localize cancer burden in excised lymph nodes
This work presents a method to detect and localize cancer burden in surgically excised lymph nodes from head and neck cancer patients. Results from porcine lymph nodes implanted with human head and neck cancer spheroids demonstrate that cancer cell clusters as small as 100-microns can be detected with >99% sensitivity and specificity within 30 min.
- 4 October 2024
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 69 (20) , 205006
Macrophage uptake rate of Sonazoid in breast lymphosonography is highly conserved in healthy controls
Subcutaneous microbubble administration in connection with contrast enhanced ultrasound (CEUS) imaging is showing promise as a noninvasive and sensitive way to detect tumor draining sentinel lymph nodes (SLNs) in patients with breast cancer. Moreover, there is potential to harness the results from these approaches to directly estimate cancer burden, since some microbubble formulas, such as the Sonazoid used in this study, are rapidly phagocytosed by macrophages, and the macrophage concentration in a lymph node is inversely related to the cancer burden. This work presents a mathematical model that can approximate a rate constant governing macrophage uptake of Sonazoid, ki , given dynamic CEUS Sonazoid imaging data. Twelve healthy women were injected with 1.0 ml of Sonazoid in an upper-outer quadrant of one of their breasts and SLNs were imaged in each patient immediately after injection, and then at 0.25, 0.5, 1, 2, 4, 6, and 24 h after injection. The mathematical model developed was fit to the dynamic CEUS data from each subject resulting in a mean ± sd of 0.006 ± 0.005 h−1 and 0.4 ± 0.1 h−1 for relative lymphatic flow (EFl ) and ki , respectively. Furthermore, the roughly 25% sd of the ki measurement was similar to the sd that would be expected from realistic noise simulations for a stable 0.4 h−1 value of ki , suggesting that macrophage concentration is highly consistent among cancer-free SLNs. These results, along with the significantly smaller variance in ki measurement observed compared to relative lymphatic flow suggest that ki may be a more precise and promising approach of estimating macrophage abundance, and inversely cancer burden. Future studies comparing tumor-free to tumor-bearing nodes are planned to verify this hypothesis.
- 4 October 2024
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 69 (20) , 205006
Macrophage uptake rate of Sonazoid in breast lymphosonography is highly conserved in healthy controls
Subcutaneous microbubble administration in connection with contrast enhanced ultrasound (CEUS) imaging is showing promise as a noninvasive and sensitive way to detect tumor draining sentinel lymph nodes (SLNs) in patients with breast cancer. Moreover, there is potential to harness the results from these approaches to directly estimate cancer burden, since some microbubble formulas, such as the Sonazoid used in this study, are rapidly phagocytosed by macrophages, and the macrophage concentration in a lymph node is inversely related to the cancer burden. This work presents a mathematical model that can approximate a rate constant governing macrophage uptake of Sonazoid, ki , given dynamic CEUS Sonazoid imaging data. Twelve healthy women were injected with 1.0 ml of Sonazoid in an upper-outer quadrant of one of their breasts and SLNs were imaged in each patient immediately after injection, and then at 0.25, 0.5, 1, 2, 4, 6, and 24 h after injection. The mathematical model developed was fit to the dynamic CEUS data from each subject resulting in a mean ± sd of 0.006 ± 0.005 h−1 and 0.4 ± 0.1 h−1 for relative lymphatic flow (EFl ) and ki , respectively. Furthermore, the roughly 25% sd of the ki measurement was similar to the sd that would be expected from realistic noise simulations for a stable 0.4 h−1 value of ki , suggesting that macrophage concentration is highly consistent among cancer-free SLNs. These results, along with the significantly smaller variance in ki measurement observed compared to relative lymphatic flow suggest that ki may be a more precise and promising approach of estimating macrophage abundance, and inversely cancer burden. Future studies comparing tumor-free to tumor-bearing nodes are planned to verify this hypothesis.
- Open Access
- 1 June 2024
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 29 (S3) , S33301-3
Pulse Oximetry: 50 Years of Inventions & Discoveries in Biomedical Optics
The editorial introduces the JBO Special Issue on Pulse Oximetry.
- 1 June 2024
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 29 (S3) , S33301-3
Open AccessPulse Oximetry: 50 Years of Inventions & Discoveries in Biomedical Optics
The editorial introduces the JBO Special Issue on Pulse Oximetry.
- 17 April 2024
- Published by Optica Publishing Group in Biomedical Optics Express
- Vol. 15 (5) , 3092-3093
Introduction to the Optical Molecular Probes, Imaging and Drug Delivery 2023 feature issue
A feature issue is being presented by a team of guest editors containing papers based on studies presented at the Optical Molecular Probes, Imaging and Drug Delivery conference as part of the Optica Biophotonics Congress in Vancouver, Canada from April 24-27, 2023.
- 17 April 2024
- Published by Optica Publishing Group in Biomedical Optics Express
- Vol. 15 (5) , 3092-3093
Introduction to the Optical Molecular Probes, Imaging and Drug Delivery 2023 feature issue
A feature issue is being presented by a team of guest editors containing papers based on studies presented at the Optical Molecular Probes, Imaging and Drug Delivery conference as part of the Optica Biophotonics Congress in Vancouver, Canada from April 24-27, 2023.
- 26 February 2024
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 52 (6) , 1625-1637
Quantifying Imaging Agent Binding and Dissociation in 3-D Cancer Spheroid Tissue Culture Using Paired-Agent Principles
Binding kinetics play an important role in cancer diagnosis and therapeutics. However, current methods of quantifying binding kinetics fail to consider the three-dimensional environment that drugs and imaging agents experience in biological tissue. In response, a methodology to assay agent binding and dissociation in 3-D tissue culture was developed using paired-agent molecular imaging principles. To test the methodology, the uptakes of ABY-029 (an IRDye 800CW-labeled epidermal growth factor receptor (EGFR)-targeted antibody mimetic) and IRDye-700DX carboxylate in 3-D spheroids were measured in four different human cancer cell lines throughout staining and rinsing. A compartment model (optimized for the application) was then fit to the kinetic curves of both imaging agents to estimate binding and dissociation rate constants of the EGFR-targeted ABY-029 agent. A statistically significant correlation was observed between apparent association rate constant (k3) and the receptor concentration experimentally and in simulations (r = 0.99, p < 0.05). A statistically significant difference was found between effective k3 (apparent rate constant of ABY-029 binding to EGFR) values for cell lines with varying levels of EGFR expression (p < 0.05), with no significant difference found between cell lines and controls for other fit parameters. Additionally, a similar binding affinity profile compared to a gold standard method was determined by this model. This low-cost methodology to quantify imaging agent or drug binding affinity in clinically relevant 3-D tumor spheroid models can be used to guide timing of imaging in molecular guided surgery and could have implications in drug development.
- 26 February 2024
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 52 (6) , 1625-1637
Quantifying Imaging Agent Binding and Dissociation in 3-D Cancer Spheroid Tissue Culture Using Paired-Agent Principles
Binding kinetics play an important role in cancer diagnosis and therapeutics. However, current methods of quantifying binding kinetics fail to consider the three-dimensional environment that drugs and imaging agents experience in biological tissue. In response, a methodology to assay agent binding and dissociation in 3-D tissue culture was developed using paired-agent molecular imaging principles. To test the methodology, the uptakes of ABY-029 (an IRDye 800CW-labeled epidermal growth factor receptor (EGFR)-targeted antibody mimetic) and IRDye-700DX carboxylate in 3-D spheroids were measured in four different human cancer cell lines throughout staining and rinsing. A compartment model (optimized for the application) was then fit to the kinetic curves of both imaging agents to estimate binding and dissociation rate constants of the EGFR-targeted ABY-029 agent. A statistically significant correlation was observed between apparent association rate constant (k3) and the receptor concentration experimentally and in simulations (r = 0.99, p < 0.05). A statistically significant difference was found between effective k3 (apparent rate constant of ABY-029 binding to EGFR) values for cell lines with varying levels of EGFR expression (p < 0.05), with no significant difference found between cell lines and controls for other fit parameters. Additionally, a similar binding affinity profile compared to a gold standard method was determined by this model. This low-cost methodology to quantify imaging agent or drug binding affinity in clinically relevant 3-D tumor spheroid models can be used to guide timing of imaging in molecular guided surgery and could have implications in drug development.